Checkup

Men concerned with prostate health sought for clinical research study

Mayo Clinic urologists are seeking to enroll men with prostate problems into a clinical research study. The study is testing the safety and effectiveness of an investigational use of an FDA-approved drug in reducing the risk of prostate cancer.

Men must be 50 to 75 years old and may suffer symptoms such as difficulty urinating and a frequent urge to urinate. Participants must have had only one negative prostate biopsy within the last six months. Volunteers meeting these and other criteria will be asked to undergo a screening visit to determine eligibility.

"This comprehensive study is exciting because it allows us to look at the potential of a complete hormone blockade drug on possibly preventing prostate cancer," says Dr. Todd Igel, the study's chief investigator.

In addition to the screening visit, participants will be asked to complete about nine clinic visits during the four-year study. All office visits and medical evaluations related to this study will be provided to qualified participants at no charge. Eligible participants may also be reimbursed for their travel and certain other study-related expenses.

Info:
(904) 953-0871